Recently, Sohrabi et al. (2020) reported that the administration of IGF1R inhibitor ameliorated Aβ accumulation and neuroinflammation in transgenic AD model mice (AβPP/PS1) [139]. The gene discussed is IGF1R; the disease is Alzheimer disease.